Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies
Researchers have developed a genetic test that can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy drugs. This means that patients who are unlikely to respond to these drugs ...
Mar 19, 2024
0
7